Literature DB >> 7706615

The important role of modifiable dietary and behavioral characteristics in the causation and prevention of coronary heart disease hospitalization and mortality: the prospective NHANES I follow-up study.

P S Gartside1, C J Glueck.   

Abstract

OBJECTIVE: Our specific aim in the prospective, longitudinal assessment of 8,251 subjects in the National Health and Nutrition Examination Survey, NHANES I, followup study was to assess the important roles of modifiable dietary and behavioral characteristics in the causation and prevention of coronary heart disease (CHD).
METHODS: Using NHANES I prospective 10 year followup data, we studied 8,251 subjects; 492 with cardiovascular events and 7,759 without events during the followup period (1971-75 to 1982-84). Using general linear models and logistic regression, we assessed the relationships of CHD risk factors to CHD morbidity and mortality.
RESULTS: By logistic regression, the following factors were independently, significantly, and inversely associated with coronary heart and vascular disease deaths and hospitalizations: alcohol intake, dietary riboflavin, dietary iron, serum magnesium, leisure time exercise, habitual physical activity, and female gender. Positive significant independent determinants of CHD events included cigarette smoking, sedimentation rate, Quetelet index, maximum body weight, and age.
CONCLUSIONS: These associations emphasize the important role of modifiable dietary and behavioral characteristics in the causation and prevention of CHD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7706615     DOI: 10.1080/07315724.1995.10718476

Source DB:  PubMed          Journal:  J Am Coll Nutr        ISSN: 0731-5724            Impact factor:   3.169


  13 in total

1.  Perspective: The Case for an Evidence-Based Reference Interval for Serum Magnesium: The Time Has Come.

Authors:  Rebecca B Costello; Ronald J Elin; Andrea Rosanoff; Taylor C Wallace; Fernando Guerrero-Romero; Adela Hruby; Pamela L Lutsey; Forrest H Nielsen; Martha Rodriguez-Moran; Yiqing Song; Linda V Van Horn
Journal:  Adv Nutr       Date:  2016-11-15       Impact factor: 8.701

Review 2.  Iron deficiency and cardiovascular disease: an updated review of the evidence.

Authors:  Emanuela Lapice; Maria Masulli; Olga Vaccaro
Journal:  Curr Atheroscler Rep       Date:  2013-10       Impact factor: 5.113

3.  Dietary iron intake and body iron stores are associated with risk of coronary heart disease in a meta-analysis of prospective cohort studies.

Authors:  Jacob Hunnicutt; Ka He; Pengcheng Xun
Journal:  J Nutr       Date:  2014-01-08       Impact factor: 4.798

4.  Association of Proton Pump Inhibitors With Higher Risk of Cardiovascular Disease and Heart Failure.

Authors:  Elizabeth J Bell; Suzette J Bielinski; Jennifer L St Sauver; Lin Y Chen; Mary R Rooney; Nicholas B Larson; Paul Y Takahashi; Aaron R Folsom
Journal:  Mayo Clin Proc       Date:  2021-10       Impact factor: 11.104

5.  Association between low serum magnesium level and major adverse cardiac events in patients treated with drug-eluting stents for acute myocardial infarction.

Authors:  Guipeng An; Zhongqi Du; Xiao Meng; Tao Guo; Rui Shang; Jifu Li; Fengshuang An; Wenjing Li; Cheng Zhang
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

6.  Low magnesium is not a significant predictor of hard events in acute myocardial infarction.

Authors:  Cristina Vassalle; Debora Battaglia; Alessandro Vannucci; Kyriazoula Chatzianagnostou; Patrizia Landi; Caterina Arvia; Clara Carpeggiani
Journal:  BBA Clin       Date:  2016-03-09

Review 7.  Circulating magnesium levels and incidence of coronary heart diseases, hypertension, and type 2 diabetes mellitus: a meta-analysis of prospective cohort studies.

Authors:  Jiang Wu; Pengcheng Xun; Qingya Tang; Wei Cai; Ka He
Journal:  Nutr J       Date:  2017-09-19       Impact factor: 3.271

8.  DASH lowers blood pressure in obese hypertensives beyond potassium, magnesium and fibre.

Authors:  Y Al-Solaiman; A Jesri; W K Mountford; D T Lackland; Y Zhao; B M Egan
Journal:  J Hum Hypertens       Date:  2009-07-23       Impact factor: 3.012

Review 9.  Magnesium and the risk of cardiovascular events: a meta-analysis of prospective cohort studies.

Authors:  Xinhua Qu; Fangchun Jin; Yongqiang Hao; Huiwu Li; Tingting Tang; Hao Wang; Weili Yan; Kerong Dai
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

10.  Canagliflozin, serum magnesium and cardiovascular outcomes-Analysis from the CANVAS Program.

Authors:  Katherine M Wang; JingWei Li; Vivek Bhalla; Meg J Jardine; Bruce Neal; Dick de Zeeuw; Greg Fulcher; Vlado Perkovic; Kenneth W Mahaffey; Tara I Chang
Journal:  Endocrinol Diabetes Metab       Date:  2021-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.